R
ecent evidence from a variety of independent investigators 1, 2 suggests that fat grafting to the breast is a procedure that can yield natural, long-term results. Because of unknown potential long-term effects of fat transplantation into the breast, careful study is warranted. In January of 2009, the American Society of Plastic Surgeons revised their position on fat grafting to the breasts, and cautioned that "results of fat transfer remain dependent on a surgeon's technique and expertise." 3 The use of preexpansion of the breast recipient site before grafting has been suggested to yield impressive long-term volume maintenance 4 ; however, there are currently few to no published data with which to evaluate this on an objective basis. The purpose of the present study was to quantify the clinical results of nonsurgical preexpansion and autologous fat grafting in breast augmentation.
PATIENTS AND METHODS
From 2007 to 2009, 25 patients (46 breasts in total) desiring breast augmentation were selected to undergo autologous fat grafting. Patients ranged in age from 21 to 60 years. Some exhibited severe unilateral asymmetry caused by Poland syndrome or other growth-related asymmetries. Patients were initially photographed and underwent threedimensional breast imaging and/or breast magnetic resonance imaging using intravenous gadolinium contrast in a 4-T breast coil (Department of Radiology and Breast Imaging, Boston University Medical Center, Boston, Mass.).
Use of BRAVA Preexpansion before Fat Grafting
Under institutional review board approval, patients underwent preoperative nonsurgical breast expansion for a period of 3 weeks by means of an external expansion device (BRAVA, LLC, Miami, Fla.). The device consisted of a rigid plastic dome with silicone gel cushioning at the base and with tubing connected to a negative-pressure pump ( Fig. 1 ). Expansion programs were individualized for each patient based on lifestyle analysis and psychological compliance testing. Patients who could not comply with their programs had their target dates for surgery extended to achieve proper preexpansion.
Patients were followed closely during preoperative expansion with serial inpatient examinations and three-dimensional breast imaging. They were encouraged to overexpand according to their desired final breast volume, following the "1-2-3 rule" (Fig. 2) .
Immediately following preexpansion, and after the patients gave their written and verbal informed consent, patients underwent autologous fat transplantation. No high-speed centrifugation was used to process fat in this patient series. Fat was allowed to separate from unwanted crystalloid and was then centrifuged at low g forces (20 to 40 g). A range of 220 to 550 cc of fat per session was injected into each breast.
In the first 24 hours after grafting, there was no external compression or negative pressure used. Beginning at 24 to 48 hours after grafting, patients were placed back into BRAVA domes, which were placed under low battery pump suction. Patients wore their external expansion devices for 2 to 4 weeks postoperatively and were followed up at regular intervals. Patients underwent a second postoperative magnetic resonance imaging examination 6 months after their fat grafting session to evaluate tissue viability, volume maintenance, and parenchymal abnormalities.
Quantitative Results: Objective Volume Measurements
Patients who completed both preoperative and 6-month postoperative breast magnetic resonance imaging (n ϭ 12) provided volumetric data sets that were subjected to analysis. All magnetic resonance imaging scans were read and all quantitative magnetic resonance imaging analyses were performed independently by the same radiologist. The radiologist responsible for all magnetic resonance imaging readings was employed at an academic medical center that was chosen on the basis of magnetic resonance imaging cost in the primary author's (D.A.D.V.) geographic area. Neither author was affiliated with this academic medical center. Baseline preexpansion volumes and 6-month postoperative volumes were measured using the semiautomated computer-generated method of volume measurement, which is considered to be the most accurate method of quantifying breast volumes by magnetic resonance imaging. 5 The average preoperative volume of the breasts measured by magnetic resonance imaging in this study was 284 cc. The average 6-month postoperative breast volume was 557 cc, for an average increase in volume of 272 cc. On a percentage increase basis, this represented a 106 percent increase, or a two-fold increase in breast volume on average. Because different clinical goals existed in each patient, there was a range of volume increases at 6 months after grafting (107 to 345 cc). Subjecting the data to paired, open-ended t testing, the difference between the preoperative Plastic and Reconstructive Surgery • June 2011 and 6-month postoperative results was statistically significant, with a value of p ϭ 0.0000003. In any given patient, volume increases were similar, and the variance between increases in breast volume was small, suggesting reliability of the technique in terms of obtaining symmetry. The raw data set is provided in Table 1 .
The average procedure time was 2 hours. Initially, the procedures took over 2 hours; however, after an initial learning curve, procedures took Volume 127, Number 6 • Breast Augmentation Using Preexpansion under 2 hours with the aid of one surgical assistant. There were no complications, including hematoma, seromas, or infections.
Qualitative Results: Radiologic Magnetic Resonance Imaging Analysis
All magnetic resonance imaging data were read by the same radiologist at the same institution using the same breast coil. In none of the cases was there evidence of newly occurring oil cysts, fat necrosis, or breast masses seen in the 6-month postoperative magnetic resonance imaging scans. The tissue that contributed to the over two-fold increase in breast volume consisted entirely of tissue that, by weighted magnetic resonance imaging, represented viable fat (Fig. 3 ).
CASE REPORTS Case 1
A 35-year-old G2P2 woman desired increased breast size. She had previously been happy with her breast volume but after several pregnancies, she lost some volume and felt her breasts were deflated. She did not want to have breast augmentation with prosthetic implants and desired a fuller appearance. She demonstrated relatively symmetric, well-developed soft breasts with no constrictions. She was initially expanded with a BRAVA handheld pump, for 10 hours per day for 3 weeks (Fig. 4) . Because she had already experienced expansion through lactation, her external expansion proceeded well. After 3 weeks of expansion, she underwent 380 cc of fat injected into each breast, harvested during liposuction of the thighs. At 6 months after grafting, her result was stable (Fig. 5) .
Case 2
A 28-year-old nulliparous woman desired increased breast size. She was pleased with the overall shape. She demonstrated relatively symmetric, well-developed, soft breasts with no constrictions or severe density. She did not desire breast implants. She was initially expanded with a BRAVA handheld pump, for 10 hours per day for 3 weeks. She was a very compliant patient, and her expansion proceeded well over serial office visits. After 3 weeks of expansion, she underwent 450 cc of fat injected into each breast, harvested during liposuction of the thighs. At 6 months after grafting, her result was stable (Fig. 6 ).
Case 3
A 32-year-old woman with tuberous breast deformity desired increased breast size and improved shape. She demonstrated constricted inframammary folds and herniation of breast parenchyma subjacent to the nipple-areola complex. She did not desire breast implants. She was initially expanded with a BRAVA Sport Pump, a low-pressure battery-operated pump, for 3 weeks before her first fat grafting procedure, during which 300 cc of processed fat was injected into each breast. She also underwent periareolar reduction. It was felt that the low negative pressure created by the Sport Pump was not ideal and that additional expansion could have been achieved by using a handheld pump with a higher vacuum pressure.
After 4 months, she underwent a second session of BRAVA preexpansion, using a hand pump, and had a second round of grafting with 300 cc of additional fat per breast. Constrictions at the inframammary fold were addressed by three-dimensional percutaneous mesh release using a 14-gauge needle immediately after fat grafting (Fig. 7) . Her results by photography and by magnetic resonance imaging before expansion and 8 months after her second procedure demonstrate a significant increase in volume and improvement in breast aesthetics (Figs. 8 and 9 ).
DISCUSSION
After Illouz first introduced liposuction as a means of reducing unwanted fat, 6 adipocyte grafting to the breast was briefly described in the literature. 7, 8 However, this had largely been placed on "standby" for the past 20 years. It was not until an accumulation of case reports, paper presentations, and patient series began appearing by independent investigators 9, 10 that the concept of fat grafting for breast augmentation was revisited, culminating in the American Society of Plastic Surgeons Breast Fat Grafting Task Force, who revised the position of the American Society of Plastic Surgeons in January of 2009. 
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We define megavolume fat grafting for breast augmentation as the transplantation of over 300 cc of fat processed at 20 to 40 g for volume for core tissue projection replacement. Because there is a wide degree of fat processing, ranging from simple decanting (1 g) to hyperconcentrated fat (3000 rpm, or 1300 g), the volume of actual graft varies depending on the concentration method used.
Based on experience with diverse breast types, it was observed that the degree of physical expansion varied not only with patient compliance wearing the expansion device but also with the mechanical compliance of the recipient site. Factoring out the degree of adherence to the expansion program as a whole, patients with dense nulliparous breasts did not expand as well as multiparous breasts in our patient series. Constricted breasts expanded well but required ancillary procedures such as nipple-areola reductions, percutaneous release of constriction bands to lower the inframammary folds, or an additional grafting session to reshape the breasts. With reference to breast augmenta- Fig. 4 . Case 1. The patient before (left) and 3 weeks after BRAVA expansion, immediately before fat grafting (right). Note that the volumetric increase is over two times that of the preexpansion state; 380 cc of fat was injected into each breast. Fig. 5 . Case 1. The patient before expansion (left) and 6 months after fat grafting (right). Note that the volumetric increase is nearly two times that of the preexpansion state. Although there is some mild ptosis, the breasts appear soft and natural, with preferential fill of the lower pole.
Volume 127, Number 6 • Breast Augmentation Using Preexpansion tion, we propose in Table 2 a hierarchy of preoperative breast morphologies that may assist surgeons in predicting for their patients the number of treatment sessions required for the desired aesthetic result.
The study period of 6 months for a postoperative magnetic resonance imaging scan was decided on based on the following logic. It is currently well accepted that grafted dermis survives by diffusion and becomes vascularized by neoangiogenesis, usually within 7 to 14 days. Once this occurs, the skin graft usually survives indefinitely. Although the exact same process cannot be assumed in fat grafting, this "diffusion angiogenesis" theory of fat graft survival is currently the most popular theory of how fat cells survive transplantation. Edema does not normally persist in human tissue 6 months following fat grafting. Fat necrosis or cysts could potentially contribute to long-term volume maintenance, but these were not seen by magnetic resonance imaging in this study.
There is clinical evidence for successful volume maintenance in breast augmentation using fat processed at high g forces (1300 g) without the use of preoperative expansion. 11 Although possible, effective volume augmentation in the unexpanded breast may be limited by high, nonphysiologic interstitial pressures reached at the recipient site and the resultant smaller volumes of fat that can be injected in one session. The same evidence for successful small graft volume (18 to 34 cc) has been reported in breast reconstruction where ancillary fat grafting has been used successfully for breast reconstruction of border-zone contour irregularities. 12 Smaller volumes of graft compared with the recipient-site volumes potentially result in maintenance of a physiologic interstitial pressure environment and a favorable surface-tovolume ratio of graft to recipient, improving oxygen diffusion in the early days after grafting. Be- A nulliparous patient with soft breasts preoperatively (left) and 6 months postoperatively (right). Even in patients in whom liposuction alone would not likely be entertained, it is often possible to obtain a sufficient amount of fat. Expansion is easier in patients with soft breasts than in patients with dense breasts. Fig. 7 . Case 3. Three-dimensional mesh release technique. Immediately after fat grafting, injected fat provides an internal traction effect to help identify specific areas of parenchymal tethering and ligamentous bands. After inserting a 14-gauge needle into multiple sites and releasing the constriction bands, the irregularity is released and the fat immediately fills the space created, changing the shape to a more aesthetic result.
Plastic and Reconstructive Surgery • June 2011 cause the injected adipocyte plays a dual role of autologous graft in need of oxygen and an internal expander, there is more demand on hyperconcentrating fat in the unexpanded breast. The more graft that is implanted, the higher the potential interstitial pressure. There is a lower mechanical/pressure limit to graft volume in the unexpanded breast scenario.
Not all patients underwent breast magnetic resonance imaging. Because this study was selffunded, some patients desired the procedure, underwent the procedure, but were not able to pay for the follow-up magnetic resonance imaging. There was no difference in patient selection, surgical technique, or clinical outcomes in patients who did or did not undergo magnetic resonance imaging. The magnetic resonance imaging data set was selected for analysis in favor of combining three-dimensional volumetric imaging data and magnetic resonance imaging data, because magnetic resonance imaging volumetric data are the most accurate and objective data available. Although only 50 percent of patients underwent both preexpansion and 6-month postoperative magnetic resonance imaging, the data set was large enough to objectively demonstrate a statistically significant volume increase at 6 months.
Comparing preexpanded breast augmentation with fat versus nonpreexpanded breast augmentation with fat, BRAVA-preexpanded breasts have the mechanical/pressure advantage of having increased parenchymal space, reducing the (Left) Anterior and right anterior oblique preoperative views of a patient with severe constricted breasts before expansion and (right) 7 months after a second session of fat grafting. Constricted or tuberous breasts can be augmented and reshaped with significant lowering of the inframammary fold through percutaneous three-dimensional mesh release. Such breasts will often require two sessions to fill the volume needed and to change breast shape. Note the significant lowering of the inframammary fold and the increased inframammary fold-to-nipple-areola complex distance postoperatively.
Volume 127, Number 6 • Breast Augmentation Using Preexpansion deleterious effect of graft crowding and interstitial hypertension. There is no requirement on the grafted cell to act as an "internal expander"; the graft simply "back-fills" the expanded parenchyma. Preexpansion of the breast recipient site eliminates the need for high-speed centrifugation and its potential disadvantages of longer procedure times and cellular damage. 13, 14 In the expanded space, a larger amount of less concentrated fat can be more diffusely dispersed and potentially survives better, with fewer assistants processing the graft, resulting in patient-safe and surgeon-friendly procedure times.
In open wounds, micromechanical forces such as vacuum elicit tissue deformation forces that stretch individual cells, thereby promoting proliferation in the wound microenvironment. The application of micromechanical forces on cells has been demonstrated as a useful method with which to stimulate wound healing through the promotion of cell division, angiogenesis, and local elaboration of growth factors. 15, 16 The deformational forces of the vacuum-assisted closure device are consistent with this mechanism of action, and are similar to the vacuum effects of external expansion to the breast that occur with use of the BRAVA device. Preexpansion to the breast may therefore be more than just "increasing space." Negativepressure therapy to the breast may demonstrate similar effects of angiogenesis, cell division, and up-regulation of growth factors, which is currently an area of laboratory study for us. To summarize, there are several key differences between classic fat grafting to the unexpanded breast and fat grafting using preexpansion, which may account for the long-term stability of the results and the larger volumes of graft used in this series, outlined in Table 3 .
One of the most misunderstood metrics in fat grafting is the use of "percentage yield" or "percentage graft survival." The concept of percentage yield represents a paradigm carry-over from twodimensional skin grafting, which cannot be readily translated to fat. Unlike the two-dimensional surface areas of dermal grafts, which are placed over Bigger overall parenchymal space, as demonstrated by photography Reduced interstitial pressure in the breast for a given volume of graft injected Augmentation of contour irregularities before grafting, so shape can be modified Variables such as high-speed centrifugation can be omitted for shorter operating room times Angiogenesis; postulated by micromechanical forces at the recipient site
The importance of immobilizing a split-thickness skin graft postoperatively is well recognized. Following grafting, the use of the BRAVA device may act as a splint. Conversely, a low negative pressure exerted postoperatively by the BRAVA bra may help immobilize the fat cells and aid in neovascularization to the graft. In any event, application of the domes in the postoperative period certainly protects the breasts from external trauma, which could inadvertently shift the graft and potentially disturb neovascularization.
This study set out to specifically examine the role of preexpansion in breast fat grafting and to describe a benchmark technique on which other techniques could be objectively compared. Because of fat's potential effect in causing cancer, the potential effects of aromatase, and the potential for fat to distort mammography, there are several difficult safety questions with no clear answer at this time. Going forward, both basic science and clinical studies will be required to specifically answer many of these questions.
